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Background/aim: To determine the epidemiology, the sociodemographic features, the incidence and prevalence rate of cancer, and the
cost of drug treatment in Northern Cyprus.
Materials and methods: All of the oncology prescriptions, cancer pathology reports, and cancer referrals to overseas for 2011 were
collected from the state hospitals, the only private university hospital that provides oncology services, and the Ministry of Health to
prepare an epidemiological database. The total cost of drug treatment at the state hospitals and cost of the most frequent five cancer
types were also calculated using the therapy protocols and the expense of the drugs.
Results: The total incidence rate for all cancer cases in 2011 was 201 per 100,000 and the prevalence rate was 460 per 100,000. The five
most common cancer types were breast (19.8%), prostate (12.6%), colorectal (9.7%), thyroid (6.4%), and lung (5.6%). The cost of drug
treatment for cancer at the state hospitals comprises 25% of the total medical budget of the Directorate of Pharmaceuticals. Almost 1/3
of this amount was spent on drug treatment of breast cancer.
Conclusion: Breast cancer is the most frequent and the most costly cancer type in Northern Cyprus. Of all the districts, the GüzelyurtLefke District has the highest cancer rate.
Key words: Northern Cyprus, cancer, epidemiology, treatment, cost

1. Introduction
Cyprus is the third biggest island in the Mediterranean,
with an area of 9251 km2, and Northern Cyprus has an area
of about 3242 km2, with a population of 294,396 (National
Planning Bureau, 2011).
Cancer is an important cause of death worldwide and
a major public health issue in the European Union (EU)
(1,2). According to GLOBACAN 2012, an estimated 14.1
million new cancer cases and 8.2 million cancer related
deaths occurred in 2012. The most commonly diagnosed
cancers worldwide were those of the lung (1.8 million, 13%
of the total), breast (1.7 million, 11.9%), and colorectum
(1.4 million, 9.7%). There are differences with regard to
decreases and increases in the incidence and mortality of
cancer types between the sexes and among countries (1,2).
In some cancer types, mortality is decreased in spite of an
increase in their incidence. For instance, improvement of
early detection programs for breast cancer plays a leading
role in reducing mortality and improving the patient’s
prognosis (1). While more than half of the cancer cases
(56.8%) and cancer deaths (64.9%) occurred in less
developed regions of the world, cancer mortality has been
reduced in developed countries, which could be attributed
* Correspondence: a.gokyigit@yahoo.com

to several factors such as advances in early detection,
improved diagnostic approaches and cancer treatment
methodology, lifestyle changes, and the development of
preventive vaccines for some cancer types (2).
Scientific progress in oncology has led to new
diagnostic tools and the development of new targeted
therapies. The cost of cancer care is expected to rise with
increased incidence in the ageing population, along with
advances in diagnostic technology and novel targeted
treatments (3). The average cost of treatment for the most
common cancers has increased as well. Recent studies
indicate that cancer drugs account for approximately 10%
of the total cancer cost (4), whereas both the number of
cancer survivors and cancer expenditures are likely to
increase in the future.
The increased incidence is explained by ageing
and growth of the global population along with other
nonmodifiable factors like genetic susceptibility (4).
Lifestyle factors such as the increase in prevalence of
female smokers, and lower rates of reproduction also
contribute to an increase in the incidence of cancers (4).
In addition to the aforementioned causes, environmental
factors such as pollutants present in the air, soil, water, and
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other media; indoor pollution from cooking and heating;
residential exposure to asbestos and radon; second-hand
tobacco smoke; diesel engine emissions; and arsenic
contamination of drinking water are common causes of
cancer (5,6).
Although the main economic activities are tourism,
university education, and agriculture in Northern Cyprus,
it is well known that in the past copper mining was an
important activity, especially around the western town of
Lefke. In terms of environmental factors, this is considered
an important issue. The aim of this paper was to provide the
figures for the basic epidemiological indicators, which are
incidence and prevalence, to determine the major cancer
types and the distribution of cancer cases in different
districts in Northern Cyprus and also to determine the
cost of drug therapy.
2. Materials and methods
There are five district state hospitals, a private university
hospital, and other private hospitals and clinics in
Northern Cyprus. However, oncology services are only
provided at the Lefkoşa State Hospital and at the private
university hospital (Near East University (NEU)). Since
cancer is the responsibility of the Ministry of Health, all
citizens of Northern Cyprus are eligible for treatment
free of charge. If the required treatment is available at
the oncology department of the state hospital, patients
receive their treatment there. If not, they are referred to
the private university hospital (NEU) in Northern Cyprus
or to eligible hospitals in Turkey by the Ministry of Health.
However, there are also patients who choose to receive
treatment in South Cyprus or overseas without local
government subsidization. These patients are not always
reported, which makes it very difficult to come up with an
exact number of cancer patients in Northern Cyprus.
In this study, all the cancer patients who receive
treatment at the state hospitals and at NEU, as well as
those referred to outside organizations were recorded.
Since there is no cancer registry in the country, data
from the state hospital was collected from the pathology
reports, the radiation oncology department, and from the
prescriptions of cancer patients for 2011. All the cancer
referral information was obtained from the Ministry
of Health, and all the data from NEU was obtained
from the pathology, medical oncology, and radiation
oncology departments for the same year. Data from the
mentioned sources were combined and a final list was
prepared on a Microsoft Excel spreadsheet including sex,
age, address, type of cancer, and date of diagnosis. Only
cases of primary cancer were considered. Missing data
regarding sociodemographic information were obtained
from the Ministry of the Interior. All the data regarding
prescriptions, reports, referrals, and sociodemographic
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information were collected with written permission from
the Ministry of Health and were treated as confidential.
This is a descriptive, cross-sectional study and all
the data are shown with descriptive statistics. For each
subgroup of categorical variables, frequency and percentage
of cancer types were calculated. For the continuous data,
mean and standard deviation were calculated. All the
calculations and data management processes were carried
out with SPSS Version 15.0 (SPSS Inc., Chicago, IL, USA).
Incidence and prevalence were calculated by standardized
rate per 100,000 inhabitants, using the population of
Northern Cyprus, which was obtained from the National
Planning Bureau.
With regard to the cost of medical treatment at the
hospitals, all the expenditure was calculated using the
Directorate of Pharmaceuticals records with written
permission from the Ministry of Health. The Directorate
of Pharmaceuticals is the body responsible for purchasing
and supplying the medicines to be used at the state
hospitals. Total expenditure on cancer drugs was calculated
to find the medical cost of cancer treatment. This was then
calculated as a percentage within the total medical cost of
the Directorate of Pharmaceuticals to find the economic
burden of the disease. Within this cost, percentages of
expenses for each of the most common five cancer types
were also calculated separately. In order to determine the
cost of drug treatment for the five most common cancer
types, therapy protocols were taken into consideration.
According to protocols, cost of drugs was calculated per
patient annually. Therefore, the total cost of the most
frequent five cancer types in Northern Cyprus was also
determined.
3. Results
The results of this study show that there were 592 new
cancer cases in 2011. The total number of patients
including the new patients and the patients who were
diagnosed prior to 2011 and were still receiving treatment
was 1354. While 52.8% (715) of the patients were female,
47% (639) were male.
The most frequent cancer type among men was
prostate (26.6%), followed by colorectal (11.3%), lung
(9.1%), bladder (7.7%), and nonmelanoma type of skin
cancer (5.5%). Among women, breast cancer was the
most frequent cancer (37.1%), followed by thyroid (9%),
colorectal (8.4%), non-Hodgkin lymphoma (5%), and
nonmelanoma type of skin cancer (4.2%). Figure 1 shows
the distribution of the most frequent cancer types by sex
and in the total population.
The predominant age group affected was 51–70 years
old including both sexes. This group made up almost half of
the cases (43.9%) for all cancers. Other age groups affected
were >71 years old (32.1%), 31–50 years old (18.6%), 19–
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100,000), Mağusa (403.8 per 100,000), and Girne (398.2
per 100,000). Figure 3 shows the distribution of the most
frequent cancer types by district.
Out of 1354 patients, 836 of them received their
treatment at the state hospitals and the cost of their drug
treatment was 11,050,532.867 Turkish Lira (TL), which
is 25% of the total medical budget of the Directorate of
Pharmaceuticals.
Total cost of the five most frequent cancer types in
Northern Cyprus was also determined. The results of this
study show that breast cancer treatment is the most costly
one (35%), followed by colorectal (6%), lung (2%), and
prostate cancer (2%) (Figure 4).
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Figure 1. Distribution of most frequent cancer types by sex and
in the total population (female 639 (53%), male 715 (47%)).

30 (3.1%) years old, and 0–12 years old (1.4%). The 13–18
years old (0.9%) age group was the least affected. Patients
were between 0 and 100 years old; the mean age was 60.83
with a standard deviation of 17.01. Figure 2 shows the
distribution of the most frequent cancer types by age.
The total incidence rate for all cancer cases in 2011
was 201 per 100,000, and the prevalence rate was 460
per 100,000. Incidence and prevalence were calculated
by standardized rate per 100,000 inhabitants using the
population of Northern Cyprus, which was obtained from
the National Planning Bureau.
The five most common cancer types among all patients
were breast (19.8%), prostate (12.6%), colorectal (9.7%),
thyroid (6.4%), and lung (5.6%).
When we compared overall cancer prevalence in
different districts in Northern Cyprus, GüzelyurtLefke had the highest prevalence (601.5 per 100,000),
followed by İskele (454.6 per 100,000), Lefkoşa (425.5 per

4. Discussion
The current study is a comprehensive scientific study with
regard to cancer in Northern Cyprus. The incidence and
prevalence rate of cancer, epidemiology, sociodemographic
features, and cost of drug treatment for cancer were all
determined for this study. All the data used here are of a
unique official nature, being obtained from the both public
and private hospitals and from the Ministry of Health;
therefore, they are the most complete available. However,
patients who seek private care abroad or in South Cyprus
are not included in the data. The results of this study
showed that there was a sex difference in cancer types and
most people involved were between 51 and 70 years old.
The five most common cancer types among all patients
were as follows: breast, prostate, colorectal, thyroid, and
lung.
In 2010, the Ministry of Health carried out a survey
consisting of five districts with a total of 7827 people.
Adults aged 18 or over who were North Cyprus citizens and
resident in private households in Northern Cyprus were
the target population in this survey. The target population
was selected to represent all the districts of Northern
Cyprus, and a multistage sample procedure was used in
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Figure 2. Distribution of most frequent cancer types by age.
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Figure 3. Distribution of most frequent cancer types by district.
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Figure 4. Distribution of the cost among different cancer types.

the design of the sample. The total number of interviews in
each district was determined according to the proportion
of the population aged 18 and over. The distribution
of the selected population was as follows: 33.8% from
Lefkoşa, 24.3% from Mağusa, 23.7% from Girne, 10.6%
from Güzelyurt, and 7.7% from İskele. Each district was
divided in two based on its level of urbanization. Urban
and rural populations and all “regional units” were covered
proportional to the number of the respective population
aged 18 or above. Finally, sampling points in each
region and houses on each street or village were selected
randomly. Face-to-face interviews were used to collect
information and participants were visited in their homes.
The survey was conducted with a standard questionnaire
developed by Cyprus Social and Economic Research
Centre (KADEM). One member of each household was
interviewed in order to obtain information about all the
members of that household. In total, 2408 interviews
were performed and information was collected for 7827
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people. The survey was conducted between October and
December 2010. The results from the survey showed that
estimated crude incidence rate per 100,000 was 549.38.
Compared with the Globacan findings on that date, the
result had fifth place after Denmark, Germany, Italy, and
Belgium (7).
According to the survey results, Mağusa had the highest
incidence rate (0.695), followed by Girne (0.668), Lefkoşa
(0.542), Güzelyurt (0.362), and İskele (0.145); and the five
most frequent cancer types were breast (35.6%), prostate
(13.3%), skin (8.9%), leukemia (8.9%), and ovarian cancer
(6.7%). Colorectal cancer was in 6th place (6.6%), and lung
cancer 9th place (4.4%) on the list (7). Some of the results
of the current study were in accordance with this survey.
The most common type of cancer was observed to be the
breast followed by prostate in both studies. However, some
findings are different from the current study such as the
district with the highest rate of cancer. The approaches of
the two studies are quite different. Considering that one of
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them is a survey and thus contains a much smaller group
of people from each district may be the reason for the
differences in the two studies.
In another study, lung cancer had the highest incidence
(24%) among males in North Cyprus (8). However, in the
current study, lung cancer ranked third among males in
frequency. It is well known that cigarette consumption and
environmental carcinogens are associated with lung cancer.
Tobacco use is a preventable cause of lung cancer. Like
the rest of the world, awareness has increased in Northern
Cyprus in recent years and tobacco use has declined.
Furthermore, contamination from the environment, such
as from the copper mines, has also declined as the mining
area was cleared in 2007. These are some factors that may
have contributed to a reduction in lung cancer rates in
recent years.
Although in the current study skin cancer was not in
the top five list for all cancers, in the study mentioned above
(8), it was in fifth place in frequency among both men and
women. The reason for this is probably exposure to the
sun. Cyprus has the warmest climate in the Mediterranean
with an average annual temperature of around 24 °C
(75 °F) during the day and 14 °C (57 °F) at night, whereas
the temperatures on the island are more extreme, with
hotter summers (Department of Meteorology, Northern
Cyprus). Considering that the summer is quite long, lasting
8 months, exposure to the sun is unavoidable. However,
people are more aware of the harmful effects of the sun
nowadays and they are more cautious, which might be the
reason for the declining number of the cases.
Breast cancer and prostate cancer have the highest
frequency among all cancers in the current study. These
two cancers are both glandular in nature and therefore
are hormone sensitive. However, it is thought that breast
cancer is mainly hereditary in Northern Cyprus, and
Hinçal et al. (8) indicated that further work is required
to clarify this issue by determining the inheritance of
mutated tumor related genes (e.g., BRCA1/2) status of
breast cancer cases in Northern Cyprus.
It is interesting that in another study (9) it was
suggested that cadmium has a triggering effect on breast
cancer development, while arsenic is a carcinogenic metal
causing skin, bladder, liver, lung, and prostate cancers. In
that study, both cadmium and arsenic were found to be
a threat in Northern Cyprus due to high concentrations
in the soil, which might be another reason for the high
frequency of breast and prostate cancers in Northern
Cyprus. Moreover, screening opportunities in both
cancers have increased, which may be an important factor
in the increase in the number of breast and prostate cancer
patients.
In the current study, colorectal cancer ranked third
among all cancers. Colorectal cancer has a strong

correlation with various factors such as poor diet, physical
inactivity, excess weight, and alcohol consumption, as well
as pesticides and insecticides (10,11). Although colorectal
cancer was in the third place overall, it was in second place
in Güzelyurt District. This is an important observation,
because Güzelyurt is an important area in terms of citrus
fruit cultivation, where insecticides/pesticides are widely
used. It is most probable that colorectal cancer is related to
insecticide/pesticide use in Güzelyurt Region of Northern
Cyprus.
Thyroid cancer was the second most common among
females and was in fourth place among all cancers in the
current study. Although the cause of thyroid cancer is not
definite, it is known that the incidence of thyroid cancer in
women is higher than that in men (12) and the results of
the current study support this hypothesis. Thyroid cancer
cases were highest in İskele District (10.5%). Among
other risk factors relevant to thyroid cancer, it is known
that iodine deficiency might be a cause of this disease
(13,14). Further investigation is necessary to conclusively
determine the reason for the high incidence rate in the
region.
Regarding the cost of drug treatment, analysis of this
study showed that 25% of the total medical costs of the
Directorate of Pharmaceuticals are spent on cancer drugs.
Breast cancer, with its high incidence and expensive
treatments, was a tremendous burden for the Department
of Pharmaceuticals, accounting for as much as 35% of
the total cost of cancer treatment. In the EU, the highest
economic cost appears to be from lung cancer (15% of
overall cancer costs), followed by breast cancer (12%
of overall cancer costs) (2). Results may vary between
countries due to differences in study methodology, in
incidence, and in management practices as well as the
characteristics of the study population, whereas costs per
patient depend on cancer stage at diagnosis, survival, and
choice of treatment (15). Treatment costs for different
types of cancer are expected to rise due to increased
number of diagnoses (due to advances in diagnostic
and surgical techniques), diagnosis at earlier stages,
pharmaceutical innovations, expected growth and ageing
of the population, and increased survival (15–17).
In conclusion, Güzelyurt-Lefke District had the
highest cancer rate in Northern Cyprus. The reasons for
the high incidence of cancer in Güzelyurt-Lefke must be
determined by carrying out a thorough research study
in the area, especially in terms of environmental factors
such as effects of mining activity and use of agrochemicals.
The frequency and cost were the highest for breast cancer,
which is an important issue in terms of budget planning.
Overall, a comprehensive cancer control and prevention
plan for Northern Cyprus is necessary. There is an urgent
need to establish a cancer registry in order to provide a
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system for more complete and more representative national
cancer registration, which will support effective cancer
control. Regarding the cost, it is obvious that introduction
of the new innovative cancer drugs, development of new
diagnostic technologies, and increase in the longevity
of the ageing population will increase the cost of cancer
treatment. Therefore, it is important to deliver affordable
cancer care systems and a sufficient budget must be
allocated for treatment costs. These data will encourage
the related official authorities to take the necessary

precautions in cancer control, to develop comprehensive
prevention plans, and to develop a sustainable health care
system.
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